. Profile of tRFs in Huh7. (A) Length distribution of tRFs (tRFs in tRF_5, tRF_3, and tRF_U3 families) (sky blue) and miRNA species (gray) in Huh7 cells (n = 2; GSM3666020 and GSM3666021). (B) Classification of the tRFs grouped according to their positions on pre-tRNA and lengths. (C) Pie chart representing the proportion of the indicated tRFs in Huh7. Bar charts represent the proportions of the indicated tRFs. (D) Proportion of the indicated tRFs belonging to the three major families, sorted by length.
. Features of the pre-tRNA 3′ trailer-derived tRFs identified in Huh7 cells. (A) Box-and-whisker plot for the liver cancer cell lines (Huh7 and Huh7-derived cell lines (n = 5); GSE128164 and GSE57381). (B) Detection of tRF_U3_1 in human primary hepatocytes (hPHs) by northern blotting as described in Figure 1D . (C) Northern blot analysis for the selected tRF_U3 family tRFs. Probes specific to the indicated trailers were used for analysis of total RNA (20 µg) from Huh7 and CCD-18Co cells along with the indicated synthetic tRFs (0.1 ng). (D) Box-and-whisker plots show relative levels of the selected miRNAs upregulated in liver cancer cells (NC, normal; C, cancer). (E) Northern blot analysis of total RNA from the indicated subcellular fractions derived from an equal number (4.5 × 10 6 ) of Huh7 cells. Cellular fractionation was verified by northern blotting for the indicated RNA markers. Nucl, nuclear fraction; Cyto, cytoplasmic fraction. Predominant, albeit not exclusive, cytoplasmic localization of tRF_U3_2 as well as tRF_U3_1 (see also Figure 1F ) is contrast to a previous observation of exclusive cytoplasmic accumulation of tRF_U3_1 (also named tRF-1001) (1) . It is not yet known whether and how pre-tRNA nuclear export is regulated in different transformed cell lines. (F) U-tail length variance in the top 23 abundant tRF_U3 family tRFs identified in Huh7 cells (see also Supplementary Table S2 ). Figure 2A as the La/SSB protein (29 matched peptides with 36% coverage and a Mascot score of 876) by LC-MS/MS analysis. Shown in red on the human La/SSB sequence are the identified peptides.
-continued next page (B) Depth plot for La/SSB-crosslinked RNAs [PAR-CLIP assay dataset (GSM2521600) from HEK293] mapped to chr10.tRNA2-Ser(TGA). The reads with at least one T-to-C conversion (solid and dotted red lines) were mainly mapped to the pre-tRNA 3′-end region (nt 65-102). (C) Preferential binding of La/SSB to the trailer 3′-end U-tail. The La/SSB-crosslinked pre-tRNA-Ser(TGA)-derived, RNase A-protected tRFs were sorted according to their starting nt positions. Red arrowhead, RNase A cleavage site; Green arrowhead, RNase Z cleavage site. (D) Depth plot for the five major read groups [> 5% of total in (C)] starting from the indicated positions (+66, +72, +73, +75, and +83 nt) and La/SSB-crosslinked sites (dark blue bar) in each group. The nt positions where at least one T-to-C conversion was detected in > 20% of reads (at least once in the five major groups) are marked by purple circles in (C). Figure S5 . The free trailer tRF tRF_U3_1 binds to La/SSB more efficiently than its precursor. La/SSB was immunoprecipitated from cell lysates of Huh7. RNA in the La/SSB immunoprecipitates was analyzed by northern blotting. Total RNA extracted from 10% of cell lysates and 5% of cell lysates (in the inputs) were also subjected to northern blotting (A) and immunoblotting (B) analyses, respectively. In (C), copy numbers of tRF_U3_1 and its precursor were determined as described in Supplementary Figure S2 . The copy number ratios of tRF_U3_1 to pre-tRNA in the input and immunoprecipitated La are presented in (D). White asterisk in (B) indicates the La/SSB. Error bars are standard deviations of three independent experiments. P values were calculated by unpaired Student t-test. **P < 0.01. Figure S6 . tRF_U3_1 is not functionally linked to the miRNA/RNAi pathway. (A) No interaction between tRF_U3_1 and Ago2 assessed by a pull-down assay followed by immunoblotting analysis. (B) Bioinformatic analysis of smRNAs associated with Ago2 immunoprecipitated from HeLa (GSE45506) and FT3-7, a Huh7-dereived cell line (GSE57381). Scatter plot of miRNAs (left) or tRF_U3 family tRFs (right) comparing input and immunoprecipitated (IP) samples. X-axis represents the abundance (log10 transformed average RPM value) of the indicated smRNAs in the input sample. Y-axis represents their abundance (average RPM value) in Ago2-IP normalized to the indicated control IP. (C) RNAi activity of tRF_U3_1 was assessed in CCD-18Co cells transfected with a dual-luciferase reporter plasmid containing the complementary sequence of tRF_U3_1 at the 3′-UTR region of the Renilla luciferase gene. At 24 h post-transfection of the reporter and tRF_U3_1 or its derivatives (10 nM each), relative normalized luciferase activity (Rluc/Fluc) was determined. Duplex tRF_U3_1 is an siRNA mimic formed with tRF_U3_1 and its antisense form (AS_tRF_U3_1). n.s., not significant (unpaired two-tailed Student t-test). (D) Predicted binding sites at the 3′-UTR of the potential tRF_U3_1 targets CDK2AP2 and EIF3B. (E) RNAi activity of tRF_U3_1 was assessed as described in (C) using a luciferase reporter carrying the 3′-UTR of CDK2AP2 (psiCHECK-2_CDK2AP2-3′UTR) or EIF3B (psiCHECK-2_EIF3B-3′UTR).
-continued next page (F) mRNA levels of predicted target of tRF_U3_1 in Huh7 cells transfected with tRF_U3_1 (100 nM). GAPDH-normalized target mRNA levels are shown as fold-changes relative to the mock-treated control.
-Immunoblotting analysis of tRF_U3_1-protein complexes pulled down from cell lysates revealed that tRF_U3_1, unlike miRNA and siRNA, did not form an RNA-induced silencing complex (RISC) by binding to Ago2. Rather, tRF_U3_1 was associated with the La/SSB (Supplementary Figure S6A ). By bioinformatic analysis of Ago2-associated miRNAs and tRF_U3 family tRFs in HeLa and FT3-7 cells, we found that tRF_U3_1 read count in the Ago2-IP sample was below baseline values in both cell lines, whereas a substantial portion of miRNAs, irrespective their expression levels, were loaded onto Ago2 (Supplementary Figure S6B ). Even the miRNAs whose expression levels were lower than that of tRF_U3_1 were enriched in the Ago2-IP samples compared to control IP samples, suggesting that tRF_U3_1 was not selectively bound to Ago2. Unlike tRF_U3_1, a limited number of tRF_U3 family tRFs were associated with Ago2 in both cell lines. Further studies are warranted to investigate whether these potentially Ago2-loadable tRFs are capable of regulating target gene expression. Using a reporter plasmid carrying tRF_U3_1 target, we demonstrated that tRF_U3_1 and its isomer tRF_U3_1(3′-4U) indeed did not display RNAi, whereas a double-stranded tRF_U3_1 siRNA mimic (duplex tRF_U3_1), but not the AS_tRF_U3_1, dramatically reduced the reporter expression (Supplementary Figure S6C ). We also investigated whether four selected potential cellular mRNA targets of tRF_U3_1 (which were among the top 64 targets with a ∆G value < −20 kcal/mol) could be negatively regulated by RNAi. Our analysis for two selected targets, cyclin-dependent kinase 2-associated protein 2 (CDK2AP2) and eukaryotic translation initiation factor 3B (EIF3B), revealed that neither of these targets, via use of the Renilla luciferase reporter system, was silenced by tRF_U3_1 ( Supplementary Figure S6D and E). Furthermore, endogenous mRNA levels of these targets and the other two predicted targets, cell division cycle 6 (CDC6) and TNF receptor-associated factor 7 (TRAF7), were largely unaffected (Supplementary Figure S6F ). These results further strengthen our conclusion that RNAi-mediated host mRNA expression regulation is unlikely to constitute the mode of action of tRF_U3_1.
Figure S7. Critical role of 3′-end U-tail in regulation of La/SSB-dependent HCV IRESmediated translation. (A)
HCV IRES-mediated translation was monitored in CCD-18Co cells transfected with the indicated single-stranded RNA oligonucleotides including tRF_U3_1 derivatives (0.1 nM). as_IRES, an antisense RNA targeting HCV IRES pseudoknot I (nt 317-337); tRF-5001, a tRF_5 family tRF [can be derived from tRNA-Ser(GCT) (chr6.tRNA61, chr15.tRNA10, chr17.tRNA123, chr11.tRNA8, chr6.tRNA43, and chr6.tRNA31)]. (B) Northern blot analysis of total RNA (15 µg) from two independent Huh7 cell cultures (#1 and #2) for tRF-5001, which was identified previously in other cell lines by Lee et al. (1) . Synthetic tRF-5001 (0.1 ng) was loaded as a control for the assay. Error bars are standard deviations of at least three independent experiments. ***P < 0.001; n.s., not significant by unpaired two-tailed Student's t-test.
-The results showed that ssRNAs bearing no U-tail at their 3′-end (as_IRES and tRF-5001, a tRF_5 family tRF not detected in Huh7) had no significant effect on La/SSB-dependent HCV IRES-mediated translation. No inhibitory activity of tRF-5001 suggested that La/SSB function was not interfered by the 5′-end region tRF separated from mature tRNA. More importantly, tRF_U3_1(ΔU17-19) as well as MT-(3′-CC) did not display the inhibitory activity. In contrast, tRF_U3_1 and its two tRF_U3_1 isomers bearing either 2U or 3U at their 3′-end significantly reduced the reporter activity, demonstrating further the important role of terminal U residues. Two days after transfection, total RNA from transfected cells and Huh7 cells, along with the in vitro transcript (IVT, 101-nt) of pre-tRNA-Ser(TGA) (100 and 500 pg), was analyzed by northern blotting using the indicated probes. (C) Partial sequence of pre-tRNA-Val(TAC) (chr10.tRNA6) with its 3′-end trailer, tRF_U3_2. Target site of sitRF_U3_2 and its predicted cleavage sites are indicated. (D) Experimental scheme for the stem-loop RT-qPCR used for quantification of trailers (see the detailed in the Materials and Methods). (E) Depletion of tRF_U3_2 and its precursor was verified by a real-time RT-qPCR using a stem-loop primer (for reverse transcription) and a pair of specific forward and reverse primers. Intracellular tRF_U3_1 and tRF_U3_2 levels in Huh7 cells transfected with a control siRNA (siCtrl) or sitRF_U3_2 (50 nM) were determined at 2 days post-transfection. From the same RNA samples, smRNAs were recovered following electrophoresis on an 8 M-15% acrylamide gel and subjected to RT-qPCR to determine the tRF_U3_2 levels normalized to tRF_U3_1 levels. U6 snRNA was used as an internal control for quantification of trailers in total RNA. Error bars are standard deviations of three independent experiments with triplicate assays. ***P < 0.001; n.s., not significant by unpaired two-tailed Student's t-test. 
Figure S15. Model for inhibition of La/SSB-dependent viral gene expression by the trailer tRFs.
Pre-tRNA synthesized by RNA polymerase III undergoes processing to remove a short 5′-leader sequence and the 3′-trailer in the nucleus. It has long been believed that the trailers are degraded after being released by RNase Z (ELAC1/2)-mediated processing. Our results show that a distinct set of pre-tRNAs might be aberrantly exported from the nucleus by an as yet unknown mechanism and be processed irrespective of the presence or absence of La/SSB in the cytoplasm. Accumulation of the trailer-derived tRFs through stabilization by La/SSB-binding to the trailer 3′ uridylate residues renders cells resistant to the RNA viruses, which usurp La/SSB as a proviral host factor, by sequestering this RNA chaperone from viral cis-acting RNA elements such as HCV and poliovirus IRES and norovirus 3′-UTR. Yet, several important questions still remain unanswered, including how pre-tRNA is exported to the cytoplasm; whether pre-tRNA processing in the cytoplasm for a certain set of tRNAs represent a general event that has not yet been explored; the mechanism by which these trailer-derived tRFs in the cytoplasm and nucleus are decayed; and whether there is an active stabilization pathway for cytoplasmic accumulation of free trailer in liver cancer cells. As we found that La/SSB is not indispensable in pre-tRNA processing, it would also be of interest what other alternative proteins with RNA chaperone activity can replace the function of La/SSB in pre-tRNA processing in mammalian cells. Table S1 . List of probes used for northern blot analysis Table S2 . tRF_U3 family tRFs identified by deep-sequencing of small RNAs in Huh7 cells Table S3 . Small RNA datasets used in this study Table S4 . Complete list of tRF_U3 family tRFs and miRNAs differentially expressed in noncancerous and cancerous human liver tissues Table S5 . Human and mouse tRNA-Ser(TGA)-coding genes 
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IgG IP FT3-7 a Huh7-derived stable cell line expressing TLR3. UK, unknown; HCC, hepatocellular carcinoma. b "-CCA", the unique sequence post-transcriptionally added to the 3′-end of mature tRNA, is not shown. c Shown are the trailer sequences, located downstream of the mature tRNA 3′-end, which bear the first four "T" residues in the predicted pre-tRNA transcripts. d For the trailer sequences that lack the four "T" residues within the 50 bases downstream of the mature tRNA 3′-end, the first 50-nt sequences in the genome are shown. b "-CCA", the unique sequence post-transcriptionally added to the 3′-end of mature tRNA, is not shown. The sequences matching the "consensus" tRNA model used in Cove analysis are presented in uppercase letters, while introns and other nucleotides in non-conserved positions are denoted by lowercase letters. c Shown are the trailer sequences, located downstream of the mature tRNA 3′-end, which bear the first four "T" residues in the predicted pre-tRNA transcripts. d For the trailer sequences that lack the four "T" residues within the 50 bases downstream of mature 3′-end, the first 50-nt sequences in the genome are shown. Among a total of 32 tRNA-Ser species, seven species have the "TGA" anticodon. The four species in green represent nuclear-encoded mitochondrial tRNAs. Shown in yellow (3 species total) are pseudo-tRNA species. Per our analysis options (see Methods in the Supplementary Information) , among the 32 predicted trailer sequences, only three species presented in sky blue were identified by deep sequencing of the small RNA library from Huh7 cells. 
5′-end of mature tRNA (1) a The tRNA number on a chromosome is based on the tRNA# in the Genomic tRNA Database (http://gtrnadb.ucsc.edu/).
Supplementary Materials and Methods
Plasmids, antibodies, and reagents
The bicistronic vector pDual-IRES, which expresses a cap-dependent Renilla luciferase (Rluc) reporter and an HCV IRES-mediated firefly luciferase (Fluc) reporter, was described previously (8) . The bicistronic vector pRPF (9) , which expresses Fluc via PV IRES, was received from Dr. Sung Key Jang (POSTECH, Pohang, Korea). The pJFH1 plasmid (10) , which was used to produce infectious HCV (genotype 2a) particles, was provided by Dr. Takaji Wakita (National Institute of Infectious Diseases, Tokyo, Japan). To overexpress the La/SSB protein, the pFlag-hLa plasmid was constructed by inserting the La/SSB cDNA (RefSeq Accession NM_001294145), amplified by reverse transcription (RT)-PCR using forward (5′-AAGCTTGGTGGTGCTGAAAATGGTGATAATGAAAAG-3′) and reverse (5′-GGATCCCTACTGGTCTCCAGCACC-3′) primers, into HindIII and BamHI sites of the pFLAG-CMV-4 vector (Sigma-Aldrich, St. Louis, MO, USA). The pFlag-hLa(∆NLS) plasmid, which expresses human La/SSB with a deletion of amino acids 375-408 including the NLS (11), was generated by PCR using pFlag-hLa as a template. The dual luciferase reporter psiCHECK-2_tRF_U3_1, containing the tRF_U3_1 complementary sequence at the 3′-UTR of the Rluc reporter, was constructed by inserting XhoI and NotI-digested duplex DNA, formed with the tRF_U3_1 forward primer (5′-TATCCCCTCGAGAAATAAGAGCACCCGCTTCGCGGCCGCCGGTAAA-3′) and the tRF_U3_1 reverse primer (5′-TTACCGGCGGCCGCGAAGCGGGTGCTCTTATTTCTCGAGGGGATAA-3′) carrying NotI (underlined) and XhoI (italic and underlined) sites, in the psiCHECK-2 vector (Promega, Madison, WI, USA), which was digested with the same enzymes. Similarly, the dual luciferase reporters containing the 3′-UTR cDNA of CDK2AP2 (RefSeq Accession NM_005851.3: nt 931-1378) and EIF3B (RefSeq Accession NM_001037283.1: nt 2529-3081) were constructed by conventional RT-PCR followed by inserting the PCR products into psiCHECK-2 to generate psiCHECK-2_CDK2AP2_3′UTR and psiCHECK-2_EIF3B_3′UTR, respectively. The ptRNA-Ser(TGA) vector expressing tRF_U3_1 was constructed based on genomic sequences of the tRNA transcription region (12) (13) (14) (15) . The gene for tRNA-Ser(TGA) on chromosome 10 was PCR-amplified from Huh7 genomic DNA, using the forward primer 5′-CCTGGCATGAGCGCAGTGGTTGTTACACTA-3′ and the reverse primer 5′-TGCTCTTCTCATGGAGCACGAAGAGTTACC-3′. The 381-bp DNA fragment was cloned into the pCR2.1-Topo vector (Invitrogen, Carlsbad, CA, USA). The IRF3-5D plasmid expressing a constitutively active IRF3 and the IFNβ-pGL3 luciferase reporter expressing firefly luciferase under the control of the IFN-β promoter (16) were kindly provided by John Hiscott (McGill University, Montreal, Quebec, Canada) and used for the interferon β reporter assays. Polyinosinic:polycytidylic acid [poly(I:C)], a double-stranded RNA analog, was obtained from Sigma-Aldrich. HCV 3′-untranslated region (UTR) in vitro transcript was prepared by T7 RNA polymerase-mediated in vitro transcription using T7 MEGAscript kit (Ambion, Austin, TX, USA) and a template amplified from pZS2 plasmid (17) (kindly provided by Dr. Christoph Seeger, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA), an HCV subgenomic replicon derived from the parental HCV Con-1 replicon I377/NS3-3′ (AJ242652), by PCR using a set of primers [forward primer, 5′-TAATACGACTCACTATAGGTAGGGGTAGGCATCTATCTA-3′ (T7 promoter: underlined) and reverse primer, 5′-ACATGATCTGCAGAGAGGCC-3′] (18) . Antibodies were obtained as follows: mouse anti-α-tubulin antibody (clone DM1A; 1:5,000 dilution) from Calbiochem (La Jolla, CA, USA), rabbit polyclonal anti-β-actin antibody (#4967; 1:5,000 dilution) and rabbit polyclonal anti-Ago2 antibody (#C34C6; 1:1,000 dilution) from Cell Signaling (Beverly, MA, USA), mouse monoclonal anti-Lamin A/C antibody (clone 14/LaminAC; 1:1,000 dilution) from BD Bioscience (Franklin Lakes, NJ, USA), mouse monoclonal anti-La/SSB antibodies (clones 312B and 44; 1:1,000 dilution) 5% CO2. The Huh7-derived cell line R-1, which supports stable, autonomous replication of genotype 1b HCV subgenomic replicon RNA, was cultivated as described previously (21) . The murine macrophage cell line RAW264.7, human embryonic kidney 293 (HEK293) or 293T (HEK293T), and human colon fibroblast CCD-18Co cells were also similarly cultivated in DMEM supplemented with 10% FBS, 100 U/ml of penicillin, and 100 μg/ml streptomycin. Huh7, HeLa (CCL-2), HEK293 (CRL-1573), HEK293T (CRL-3216), CCD-18Co (CRL-1459), and RAW264.7 (TIB-71) cells were purchased from the American Type Culture Collection (ATCC, Rockville, MD, USA). Normal human primary hepatocytes (HH, #5200) were purchased from ScienCell Research Laboratories (Carlsbad, CA, USA) and cultivated according to manufacturer's recommendations. The liver tissues used to prepare primary hepatocytes were obtained from patients with informed consent from donor or donor's family aged over eighteen years. hPBMCs were grown in DMEM supplemented with 10% FBS, 100 U/ml penicillin, and 100 µg/ml streptomycin.
Establishment of tRF_U3_1 and La/SSB knockout cell lines tRF_U3_1 knockout Huh7 cells were generated using the CRISPR-Cas9 genome editing system as described previously (22) . Briefly, a 20-bp guide sequence (5′-ACCCGCTTCCGCAGCGAGCA-3′) targeting the mature tRNA-Ser(TGA) gene on chromosome 10 was selected from the candidate sites predicted by Off-Spotter (23) . Two complementary oligos 5′-CACCGACCCGCTTCCGCAGCGAGCA-3′ and 5′-AAACTGCTCGCTGCGGAAGCGGGTC-3′, containing the guide sequence were annealed and phosphorylated. The annealed oligo was then ligated into the BbsI-digested pX330 vector (Addgene, Cambridge, MA, USA). Similarly, La/SSB KO Huh7 cells were generated using the two 20-bp guide sequences (5′-TTGGCGACTTCAATTTGCCA-3′ and 5′-TCCTTTAGAAACTTGTCCCG-3′) targeting the La/SSB-coding gene on chromosome 2, which were selected from the GeCKO v2 library (24) and cloned into the pX330 by the procedure described above. Huh7 cells grown in 24-well culture plates were transfected with 500 ng of the vector using FuGENE HD transfection reagent (Promega). At 72 h posttransfection, serially diluted cells were plated in 10-cm dishes to isolate single cell-derived colonies. Candidate KO colonies were screened by sequencing and verified by northern blotting or immunoblotting. For sequencing, genomic DNA was extracted using the Wizard Genomic DNA purification kit (Promega), and the target loci were PCR-amplified and cloned into the pCR2.1-Topo vector (Invitrogen) for sequencing analysis.
Virus infection and transfection
Infectious JFH1 HCV RNA (genotype 2a, AB047639) was prepared by in vitro transcription using the T7 MEGAscript kit (Ambion) and electroporated into Huh7 cells as described previously (21) . Cell culture-derived HCV (HCVcc) was collected from culture media by centrifugation at 2,000 × g for 10 min, followed by passing through a 0. (25) . Plaque forming assay for MNV-1 was performed as described previously (26) .
Small RNA library construction
Total RNA was extracted from Huh7 cells and human liver tissues with TRIzol reagent (Invitrogen) and purified according to manufacturer's recommendations. The isolated RNA was prepared for Illumina sequencing using the TruSeq Small RNA Sample Preparation kit (Illumina) according to manufacturer's protocol. Briefly, RNA was ligated with 3′ (5′-ppTGGAATTCTCGGGTGCCAAGGNH2-3′) and 5′ (5′-GUUCAGAGUUCUACAGUCCGACGAUC-3′) adapters using T4 RNA ligase and was reverse-transcribed to cDNA with the Illumina RNA RT primer (5′-GCCTTGGCACCCGAGAATTCCA-3′). The cDNA was amplified using Illumina RNA PCR primer sets (5′-GCCTTGGCACCCGAGAATTCCA-3′ and 5′-CAAGCAGAAGACGGCATACGAGATTGACATGTGACTGGAGTTCCTTGGCACCCG AGAATTCCA-3′). The PCR products were size-fractionated by electrophoresis on a 5% Tris/borate/EDTA polyacrylamide gel to recover DNA fragments in the range of 140-180 bp by electroelution. The resulting small RNA library was limited to small RNAs with a 5′ monophosphate because adapter ligation requires this terminal moiety.
Mapping and annotation of small RNAs
The reads (≥ 10 reads) were mapped using the Bowtie (version 1.0.1) software (27) with the "-v 2 -m 10 --best --strata" options. Reads that could be aligned to the human genome were moved to the "mapped" data set and suppressed reads were discarded to prevent multiple mapping for further alignment. The remaining reads were aligned to the tRNA sequences in a custom tRNA database, in which mature tRNA contained the post-transcriptionally-added CCA at the 3′ end of mature tRNA sequences (28) , allowing identification of tRF_3 family tRFs. After mapping, only unique reads of the "mapped" data set were annotated using GtRNAdb (http://gtrnadb.ucsc.edu (29) : for tRNA-derived tRFs matching to mature tRNA sequences without any mismatches), miRDB (miRbase database release v20, http://www.mirbase.org) (30) , and the database for known non-coding RNAs (ensembl database Homo_sapiens.GRCh37.75.ncrna.fa, http://www.ensembl.org). The reads annotated as ribosomal RNAs were removed. For read analysis for tRNA-derived tRFs, the sequences matching to both tRNA sequences and other genome sequences were excluded. For sequences matching to more than one tRNA, read number was divided equally into individual tRNAs.
Bioinformatic analysis of small RNA deep sequencing datasets
The small RNA high throughput sequencing data for human non-cancer liver tissue (n = 22), liver cancer tissue (n = 14), and HCC lines (n = 5) were collected from in-house small RNA libraries or downloaded from the NCBI Gene Expression Omnibus (GEO) and the Sequence Read Archive (SRA). The accession numbers of datasets from NCBI GEO and SRA and details of the in-house libraries are presented in Supplementary Table S3 . Small non-coding RNA profiling for these datasets was performed using the procedure described above. The DESeq2 package (31) was used for differential expression analysis for the tRF_U3 family and miRNAs with standard parameters. The log2 fold-changes of tRF_U3 family and miRNA reads (Padj < 0.05 and baseMean ≥ 50) from the non-cancerous and cancerous liver tissues are listed in Supplementary Table S4 . The La PAR-CLIP (photoactivatable ribonucleosideenhanced crosslinking and immunoprecipitation) assay datasets (4) were downloaded from the GEO database (GSE95683). Reads (≥ 16 nt) from the PAR-CLIP datasets were aligned using the Bowtie software (27) to the tRF_U3 family tRFs with the allowance of two mismatches.
Nano LC-MS/MS analysis
Nano LC-MS/MS analysis was performed on an Agilent 1100 Series nano-LC and LTQ-mass spectrometer (Thermo Electron, San Jose, CA, USA) using a capillary column (150 mm × 0.075 mm; Proxeon, Odense M, Denmark) packed in house with 5 µm, 100-Å-pore size Magic C18 stationary phase (Michrom Bioresources, Auburn, CA, USA). Mass spectra were acquired using data-dependent acquisition with full mass scan (350−1800 m/z) followed by MS/MS scans. The mascot algorithm (Matrix Science, Boston, MA, USA) was used to identify peptide sequences present in a protein sequence database.
Subcellular fractionation
Huh7 cells suspended in buffer A [250 mM HEPES (pH 7.4), 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, and protease inhibitor cocktail (Roche, Basel, Switzerland)] were lysed by passing through a 30-G needle 10 times using a 1-ml syringe. After 20 min incubation on ice, unbroken cells and nuclei were pelleted by centrifugation at 720 × g for 5 min. The cytosolic fraction was obtained from the supernatant collected by centrifugation at 100,000 × g for 1 h. Unbroken cells and nuclei pellets were washed with buffer A and passed through a 30-G needle 10 times. The nuclei pellet collected by centrifugation at 1,000 × g for 10 min was then suspended in buffer B [50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS, 10% glycerol, and protease inhibitor cocktail (Roche)] and sonicated on ice two times for 3 sec, prior to analysis by northern-and immuno-blottings.
Northern blot analysis
For small RNA detection, DNA oligonucleotide probes were end-labeled with [γ-32 P] ATP using T4 polynucleotide kinase (Takara, Kyoto, Japan). Total RNA (20 µg) extracted from cells using TRIzol reagent (Invitrogen) was resolved by electrophoresis on a 15% polyacrylamide-8 M urea gel and electrically transferred to positively charged nylon membranes (Roche) . The membrane was UV-crosslinked, pre-hybridized with salmon sperm DNA (20 μg/ml; Invitrogen), and then probed in hybridization buffer (5× SSPE, 5× Denhardt's solution, and 0.5% SDS). After washing twice at 37°C with a washing buffer solution (6× SSC and 0.5% SDS) for 5-15 min, the blot was analyzed by Phosphorimager (BAS-2500; Fuji Film, Tokyo, Japan).
Real-time RT-qPCR
Total RNA was extracted with TRIzol (Invitrogen) and purified according to the manufacturer's procedures. Intracellular HCV RNA levels were quantified using the iQ Supermix RT-PCR kit (Bio-Rad) as described previously (32) . MNV RNA levels were quantified as described previously (33) . Fluorescence was detected using the CHROMO4 continuous fluorescence detector (MJ Research, Waltham, MA, USA). RT-qPCR analysis of mRNA levels was performed using SYBR Premix ExTaq (Takara) and specific oligonucleotide primers for target sequences. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) served as the endogenous control. The following primers were used as described previously (34) and elsewhere: IFN-β, forward primer 5′-GAACTTTGACATCCCTGAGGAGATTAAGCAGC-3′ and reverse primer 5′-GTTCCTTAGGATTTCCACTCTGACTATGGTCC-3′; CDK2AP2, forward primer 5′-TGTTTAACGACTTTGGACCGC-3′ and reverse primer 5′-CCATCTCCTCTATGACTGACAGC-3′; EIF3B, forward primer 5′-CCGGGTCAACCTCTTTACGG-3′ and reverse primer 5′-GAAGTGCGGTCTCCACTCTC-3′; CDC6, forward primer 5′-ACCTATGCAACACTCCCCATT-3′ and reverse primer 5′-TGGCTAGTTCTCTTTTGCTAGGA-3′; TRAF7, forward primer 5′-TCTGCGCTCCACATTCTCAC-3′ and reverse primer 5′-ACCGCGATGTTCTTCACCA-3′; U6 snRNA, forward primer 5′-CTCGCTTCGGCAGCACATATACT-3′ and reverse primer 5′-ACGCTTCACGAATTTGCGTGT C-3′, and GAPDH, forward primer 5′-GAAGGTGAAGGTCGGAGTC-3′ and reverse primer 5′-GAAGATGGTGATGGGATTTC-3′. For U6 snRNA cDNA synthesis, an RT-primer 5′-
